Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant in Newly Diagnosed Glioblastoma (GBM)

NCT05342883 is registered in ClinicalTrials.gov with GT Medical Technologies, Inc. as lead sponsor.

NCT NCT05342883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05342883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant in Newly Diagnosed Glioblastoma (GBM)
Lead sponsor
GT Medical Technologies, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 17, 2022
Completion date
December 1, 2027
Enrollment
61 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma